Authors: Davies, FE Forsyth, PD Rawstron, AC Owen, RG Pratt, G Evans, PAS Richards, SJ Drayson, M Smith, GM Selby, PJ Child, JA Morgan, GJ

Citation: Fe. Davies et al., The impact of attaining a minimal disease state after high-dose melphalan and autologous transplantation for multiple myeloma, BR J HAEM, 112(3), 2001, pp. 814-819

Authors: Rawstron, AC Kennedy, B Evans, PAS Davies, FE Richards, SJ Haynes, AP Russell, NH Hale, G Morgan, GJ Jack, AS Hillmen, P

Citation: Ac. Rawstron et al., Quantitation of minimal disease levels in chronic lymphocytic leukemia using a sensitive flow cytometric assay improves the prediction of outcome andcan be used to optimize therapy, BLOOD, 98(1), 2001, pp. 29-35

Authors: Tobal, K Newton, J Macheta, M Chang, J Morgenstern, G Evans, PAS Morgan, G Lucas, GS Yin, JAL

Citation: K. Tobal et al., Molecular quantitation of minimal residual disease in acute myeloid leukemia with t(8;21) can identify patients in durable remission and predict clinical relapse, BLOOD, 95(3), 2000, pp. 815-819

Authors: O'Connor, SJM Evans, PAS Morgan, GJ

Citation: Sjm. O'Connor et al., Diagnostic approaches to acute promyelocytic leukaemia, LEUK LYMPH, 33(1-2), 1999, pp. 53